Navvis & Company Events: Archive
Women and Heart Disease: 2010 Update – March 31 2010, 12:00pm - 1:00pm Central
Ten years ago, Yale New Haven Hospital in New Haven, CT launched an important national initiative to increase awareness and improve clinical outcomes for women with heart disease. This program was called Women's HeartAdvantage®. When it began, only 30% of women in the United States were aware of heart disease as their number one health risk. Today, 60% now know this although the fact remains that only 13% of women recognize it as their own greatest personal risk. There's still work to be done in this regard and Women's HeartAdvantage continues to play an important role to this end.
Join us on Wednesday, March 31st at 12pm EDT as WHA national co-chairperson, Dr. C. Noel Bairey Merz, one of the nation's leaders in the work with women and heart disease, gives us a brief retrospective of the journey, an update on the latest trends and a sneak peek into what the next decade may hold for women and heart disease.
In particular, Dr. Merz will focus on:
- Clinical trial update including the JUPITOR and COURAGE trials - what trends are we seeing today?
- Microvascular disease in women - how does it impact the types of screenings, diagnostics and therapeutic modalities used today?
- From simple to complex - what are the most appropriate general cardiovascular screenings and diagnostic applications for women?
- Allied-health screening programs - what are women's heart screening protocols that can be deployed with PCPs, that will develop collaborative relationships and encourage women to take more responsibility for their heart health?
- A brief glimpse into the future - what might the next decade bring?
- How can Women's HeartAdvantage clients align with the future to ensure women and heart disease remains a focal point of cardiovascular service lines?
